Everything behind the call on Teva Pharmaceutical Industries Limited. 6 sections, ordered the way risk stacks up: survival first, quality and price in the middle, context last. The Beacon gives you the read. This is where you check the work.
The five reads
Global tape
No overseas listings — TEVJF trades on its home exchange only.
The bottom linestart here
Earnings
In 38 days
4 Nov 2026
cohort P(beat) 61% · n=139,854
Dividend
0.00%
A rounding error against cash — this is a capital-gains position
Risk flags
1 critical
5 checks run, 3 clear
worst drawdown -2%
New to this? Every metric carries a plain-English read beside it, and an ⓘ next to a label opens the definition. Anything unfamiliar is also defined at the foot of the page under Glossary.
In one paragraphwhat the company actually does206 chars
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
OTC Markets OTCPK · USDSpecialty & Generic Pharma
$38.98+1.98 · +5.35%CLOSED · vol 5.47M
52-week range↑ 172% off low · ↓ 1.8% off high
$14.32now $38.98$39.70
Quote Sep 18, 2026 · 4:00 PM ET Tape 2026-09-18
01
Survival & solvency
and 3 of 5 forensic checks clear.
↳ Plain EnglishBefore anything else: can this company pay its bills? These blocks check the balance sheet, whether your slice of ownership is being diluted, and whether the accounting looks honest.
Piotroski F-score
F 8/9CLEAR
Piotroski F-score 8 of 9. Nine pass/fail tests covering profitability, leverage and operating efficiency; seven or more is strong.
Balance sheetSep 26, 2026
Solvency and liquidity ratios
Current ratioshort-term assets against short-term bills1.04×healthy >2
Debt / equityborrowings against shareholder capital2.16
Net debtborrowings in excess of cash on hand$13.54B
Your ownership stake
Share-count growth vs peersHIGH DILUTION
59th pctile
Where this name's share-count growth ranks among peers. Lower is less dilutive.
Net buyback yieldISSUING
0.00%
Buybacks less new issuance, as a share of market value.
Buyback yieldGROSS
0.00%
Repurchases as a share of market value, before new issuance is netted off.
Stock-based comp / revenueIN LINE
0.9%
Stock comp is the dilution pressure a buyback has to outrun. We read up to 5% of revenue as modest and above 12% as heavy — our own reading band, not a measured peer statistic.
Diluted vs basic share gapTHIN OVERHANG
1.57%
Options and awards already granted, expressed as the gap between the diluted and basic counts.
Accounting forensicsSEC filings
Red-flag x-rayGRADE B
70 / 100
1 critical · 1 watch · 3 clear of 5 scored tests
3 of 5 checks clear
Red-flag x-ray · every check, passes included
CheckStatusValueWhat it looks for
Bankruptcy distressCRITICALZ 0.93Altman-Z in the Distress · fundamentals
Earnings manipulationCLEARM -2.35M-score in range · fundamentals
Profitability qualityCLEARF 8/9Piotroski F-score 8 of 9 · fundamentals
Filing forensicsCLEAR0 flagsno filing red flags on the latest 10-K · forensic
5 checks, 3 clear and 1 watch and 1 critical. The passes are shown because a score built from five checks means something different from one built from three.
02Refreshed · Sep 26, 2026FAIR · 53/100
Business quality
8% net margin, 18% return on equity, +4% revenue growth, and capital earning 15% against a 5% cost.
↳ Plain EnglishMargins tell you how much of each sales dollar the company keeps. Return on capital tells you whether reinvesting that money creates value. Both are read against what the filings support, not against a target.
Quality score
53 / 100FAIR
Profitability · net margin 8%
Growth · revenue +4% YoY
Balance strength · debt/equity 2.16
Profitability, growth and balance strength scored separately, then blended.
ProfitabilityRefreshed · Sep 26, 2026
Net marginOF EVERY SALES DOLLAR
8.2%
The share of revenue that survives every cost and becomes profit.
Gross marginPRICING POWER
51.8%
What is left of a sales dollar before overhead — the clearest read on pricing power.
Operating marginAFTER RUNNING COSTS
22.9%
What survives the cost of running the whole business.
Return on equityPER $1 OF EQUITY
17.8%
Annual return on each dollar of shareholder equity.
ROIC − WACC spreadCREATES VALUE
9.9pp
Earns 15% on invested capital that costs about 5%. A positive spread means every retained dollar compounds rather than leaks.
Asset growth vs peersIN LINE
48th pctile
The balance sheet grew +4% on the year. Fast asset growth is usually a ramp; occasionally it is the start of an inventory problem.
Typical earnings moveData unavailableRealized move magnitudes are not published for this name yet — no measured print on file.
Reaction: beat vs missData unavailableThe beat-versus-miss reaction gap is not computed for this name — undetermined — needs ≥12 measured beats.
Consensus biasVALIDATED
Persistent
insufficient surprise history
Next reportIN 38 DAYS
4 Nov 2026
Reports amc · revenue 4.3 B
Dividends & income
Data unavailableThis company does not pay a dividend. There is no yield, payout ratio or ex-dividend date to show, and the return case rests entirely on capital gains.
Signal
Not an income position.
No dividend is declared, so nothing here contributes to total return except the price. That is a fact about the security, not a criticism of it.
Inventory ledger
Data unavailableNo inventory detail is tagged in this company's filings. The ledger needs the XBRL inventory components, which a business without physical goods does not report.
Segments & geography
Data unavailableRevenue by segment and region is not on file for this name, so product and geographic concentration are not shown.
↳ Plain EnglishA multiple is what the market charges for a dollar of this company's earnings, cash or revenue; the trend and the options tape say what the price is doing around it. Together they are the timing picture, not the quality one.
Momentum (RSI-14)
88OVERBOUGHT
030 oversold70 hot100
Where momentum sits on a 0–100 scale. Above 70 is overbought, below 30 oversold; the middle says the move has room either way.
The setup right now
Price · 504 sessions2024-09-16 → 2026-09-18
price50-day200-day
How to read this
Up 5.35% on the session.
Follow the solid line: each point is a session close. Compare it to the 50-day average — while price stays above it the short-term trend is up, and a drop below is the first structural warning.
Market cap$45.42B
Day range$32.89 – $38.98
Above 52-week low+172%
Worst drawdown-1.8%
MACDABOVE SIGNAL
+0.62
The short-term trend against its own signal line. The sign is the read; the size is not a target.
Pivots (classic)R1 $39 · S1 $39
$39.01
The last settled session's range projected forward. Reference levels, not predictions — after a big gap they can sit on the wrong side of the price until the next close.
DeMark countdownUP SETUP
2 of 9
Counts consecutive closes against the prior trend. A completed 9 often marks exhaustion.
4 Nov 2026 · in 38 daysNext earningsThe next scheduled catalyst. The forward guide usually moves the tape more than the printed number. Date as the vendor last stated it on 31 Jul; companies confirm about three weeks ahead, so it can still move.
2026-09-29 · in 2 daysJob Openings (JOLTS)A scheduled macro release. It moves this stock independently of anything the company does.
Setup & oddsNightly
Pullback riskoverstretch read
In line1.00× segment rate · n=45,201
Historically, large names in this tape state saw a ≥10% pullback within 63 trading days in 66% of cases (n=45,201).
Valuation
Earnings yield vs cashBELOW CASH
-3.36pp
Cash pays more than the earnings yield today, so what you are buying is future growth rather than a current return.
Net cash per shareNET DEBT
$-10.78
Cash less every borrowing, per share. It is the part of the price that is not a claim on future profits.
Multiples
Trailing P/Eearnings already reported65.0×
Price / salesprice against revenue, before any of it becomes profit2.6×
Price / bookprice against the accounting value of the assets5.7×
EV / EBITDAthe multiple an acquirer would pay18.8×
EV / free cash flowenterprise value against the cash the business throws off51.4×
FCF yieldfree cash flow per dollar of market value2.53%
4 of the 6 priced multiples above sit in the richer half of its band. Each priced multiple is read against this stock's own history where a five-year range is on file, so the question is whether today is dear for this name rather than for the market. The multiples are computed separately from the quote above and are not re-priced as it moves, so they can lag it.
Price horizon & timing
Data unavailableThis security is delisted, so there is no live tape to compose entry, target and stop against.
Gamma map
Data unavailableThis name has no listed options chain, so there is no dealer gamma to map. Regime, flip level, walls and the implied move all need a chain to exist.
Options tape
Data unavailableNo options chain is connected for this ticker. Max pain, the put/call ratio, the implied move and the open-interest ladder all need the chain feed.
0413F quarterly · Form 4 dailyNET SIGNAL 0
Ownership & flow
Institutions hold 23%.
↳ Plain EnglishWho is buying and selling, and what they had to disclose. Institutions file 13F 45 days after quarter end, executives file Form 4 within two days, and Congress discloses under the STOCK Act with a 30–45 day legal lag. Every one of those is a look backwards.
Institutional ownership
23.0%RETAIL-HEAVY
The share held by 13F filers. It describes last quarter's positioning, not today's — filings land up to 45 days after quarter end.
The QTick signal
Data unavailableNo factor in the model scored for this name, so there is no net signal to show. The signal appears once the nightly factor run covers it.
Cross-category read
Data unavailableFewer independent evidence families are ready than the engine's minimum, so there is nothing to check for agreement. A cross-category read over two categories is not a read.
Wall Street
Data unavailableNo sell-side firm publishes research on this name. There is no consensus rating, no price target and no estimate revisions to weigh — for a company this size that is the norm rather than a gap in our data.
Who owns it13F quarterly · Form 4 daily
Insider ownershipOFFICERS & DIRECTORS
0.5%
The share held by the people running the company.
Free float93% OF SHARES
1.08B
Shares actually available to trade, excluding insider and restricted holdings.
Dollar volume (ADV)69th PCTILE
$16.91M/day
Average dollars traded per day, and where that ranks cross-sectionally. Thin liquidity is a cost you pay on the way out, not just on the way in.
Borrow feeData unavailableWe do not license securities-lending data, so the annualized cost of borrowing shares to short is not something we can show. Short interest and days-to-cover above are the closest read we can source.
The story · news & sentimentRolling window
Why it moved on Sep 24, 2026TECHNICAL
+5.35%
TEVJF rose +5.35% since the last close, with RSI at 88 (overbought).
Matched · Sep 24, 2026
Congress
Data unavailableNo congressional trades in this name have been disclosed under the STOCK Act. Lawmakers' disclosed trades cluster heavily in large caps, so an empty list is the usual state.
050 graded calls
Risk & track record
a -2% worst drawdown, and 2 of 8 risk surfaces clear.
↳ Plain EnglishWhat owning it does to a portfolio, what the model votes against, and how often our own calls have been right. Every call is graded when it resolves, and the ones still open stay visible.
Max drawdown
-1.8%WORST FALL
The deepest peak-to-trough fall in the measured window. Only hold a position you can watch do this.
What it does to a portfolio5-year window
What votes against
Data unavailableNo factor in the model currently votes against this name. That is a statement about the model's inputs today, not a claim that nothing could go wrong.
Failure modes · by company type
Data unavailableFailure modes are routed per company type, and only the bank-run and crypto-treasury rulebooks are validated so far. This name routes as growth, so there is no cohort-specific checklist to run. A generic list would read as analysis without being any.
The risk case · why not to buy8 surfaces · nightly
Avoid score6-month distress
0.6%0.1× its cohort · most-traded mega-caps
Observational 6-month large-drawdown risk ranking — not a forecast, not alpha. Historical distress rate for this most-traded mega-caps segment: 9.3%. This name reads 0.1× that base rate.
LowDistress screenThe distress model did not score this name in the latest run, so this surface is unmeasured rather than clear.Not scored
LowPosition sizeThe sizing model has not covered this name, so no defensible cap is published for it.Not scored
LowLottery-ticket behaviourNot scored for this name.Not scored
LowPost-earnings driftNo measured earnings reaction on file, so the drift surface is unmeasured.Not scored
LowDividend riskNot scored for this name.Not scored
LowRestatement historyFiling history is not deep enough to check for restatements.Not scored
LowCrowded shortNot in a warn state: the crowded-short model only publishes when short interest and thin liquidity coincide, and neither condition is met here.Not scored
Signal
2 of 8 surfaces clear.
8 surfaces checked, 2 clear. Each row states which surface it is and what it measured; a surface that could not be scored says so rather than counting as clear.
Who should skip it
Skip it if any of these is you
You want income
A 0.00% yield is a rounding error against cash. This is a capital-gains position.
You'd be buying into earnings
A report lands in 38 days.
Our track record0 resolved
Track recordBUILDING IN THE OPEN
8 logged
8 calls logged on this name, 0 resolved so far. Calls are logged the moment they are made, so the open ones are public before anyone knows how they turn out, and a hit-rate is not published until enough of them resolve.
0 resolved · 8 open
Calls on TEVJFTHIS NAME
8
This name's own call count. Too few have resolved to publish a rate over them, so none is shown rather than a rate over 0.
0610-K disclosed linksSPECIALTY & GENERIC PHARMA
The wider context
5 mapped peers.
↳ Plain EnglishCompanies do not trade alone. This is the peer set, the supply chain that has to deliver, and the macro variables that move the stock regardless of company news.
Rate sensitivity
0.0% per +1ppINSUFFICIENT
This is the SECTOR prior, not a measurement of this name — the regression did not clear its own bar. The verdict beside it (neutral) comes from the prior too, so the two agree by construction rather than by evidence.
Versus peersLatest session
Peer set · 5 names
SymbolRelationshipPriceSession
JHPCYPeer$11.500.00%
GDERFPeer$203.60-0.91%
TAKPeer$18.86+1.45%
GALDYPeer$39.45+0.31%
TKPHFPeer$37.000.00%
The mapped peer set and how each traded in the latest session. A peer moving with this name says the move is the sector's; one moving against it says the move is this company's.
That is the definition of a stock that has already worked, and it says nothing about the next window. What it does tell you is what a drawdown would be measured against.
Historical retrospective. Context, not a forecast.
Macro driversRolling window
Inflation (CPI) reactionn=39
3.39×
On these days it moves about 3.4× the market, regardless of company news.
Measured over 39 events
Jobs report reactionn=40
0.83×
On these days it moves about 0.8× the market, regardless of company news.
Measured over 40 events
Fed decision (FOMC) reactionn=39
0.54×
On these days it moves about 0.5× the market, regardless of company news.
Measured over 39 events
Inflation (PCE) reactionn=39
0.91×
On these days it moves about 0.9× the market, regardless of company news.
Measured over 39 events
Next macro catalystIN 2 DAYS
Job Openings (JOLTS)
2026-09-29. A scheduled release that moves this stock independently of anything the company does.
On the day +0.4% · A week later +1.6% · Two weeks later +3.0% · Rose on 9 of 170 report days
Across the last 170 Initial jobless claims reports since Jun 8, 2023, TEVJF moved +0.4% on average on the day and was 3.0% higher two weeks later. The S&P 500 moved 0.0% on those days.
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day -0.8% · A week later +0.5% · Two weeks later +2.6% · Rose on 1 of 39 report days
Across the last 39 Core PCE (the Fed's gauge) reports since Jun 28, 2023, TEVJF moved -0.8% on average on the day and was 2.6% higher two weeks later. The S&P 500 moved +0.2% on those days.
On the day +0.6% · A week later +1.5% · Two weeks later +5.6% · Rose on 2 of 39 report days
Across the last 39 FOMC decision reports since Jul 1, 2023, TEVJF moved +0.6% on average on the day and was 5.6% higher two weeks later. The S&P 500 moved -0.1% on those days.
On the day +1.7% · A week later +0.1% · Two weeks later +0.9% · Rose on 4 of 39 report days
Across the last 39 Housing starts reports since Jun 20, 2023, TEVJF moved +1.7% on average on the day and was 0.9% higher two weeks later. The S&P 500 moved 0.0% on those days.
On the day -0.4% · A week later +1.1% · Two weeks later -0.1% · Rose on 1 of 39 report days
Across the last 39 Industrial production reports since Jun 15, 2023, TEVJF moved -0.4% on average on the day and was 0.1% lower two weeks later. The S&P 500 moved +0.1% on those days.
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day -0.8% · A week later +0.5% · Two weeks later +2.6% · Rose on 1 of 39 report days
Across the last 39 PCE inflation reports since Jun 28, 2023, TEVJF moved -0.8% on average on the day and was 2.6% higher two weeks later. The S&P 500 moved +0.2% on those days.
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +2.2% · A week later +5.1% · Two weeks later +4.8% · Rose on 8 of 39 report days
Across the last 39 Producer prices (PPI) reports since Jun 12, 2023, TEVJF moved +2.2% on average on the day and was 4.8% higher two weeks later. The S&P 500 moved +0.3% on those days.
On the day -0.4% · A week later +1.1% · Two weeks later -0.1% · Rose on 1 of 39 report days
Across the last 39 Retail sales reports since Jun 15, 2023, TEVJF moved -0.4% on average on the day and was 0.1% lower two weeks later. The S&P 500 moved +0.1% on those days.
Customer momentum
Data unavailableCustomer momentum needs listed customers that disclose a revenue dependence on this company, and none is on file. The connections below are a different map: competitors and partners, most of them curated rather than filed.
Connections
Data unavailableNo competitor, partner, supplier or customer relationship is on file for this name yet.
Glossary · every term on this page
Survival
Altman Z
Bankruptcy-risk score. Above 3.0 is the safe band.
Piotroski F
Nine pass/fail health tests; 7 or more is strong.
Beneish M
Accrual and growth pattern screen. Clear below −2.22, watch to −1.78, elevated above; a year of very fast revenue growth lifts it by construction.
Merton DTD
Standard deviations of asset value between the company and its debt.
EDF
Default frequency calibrated on what actually happened to similar names.
Price & tape
RSI-14
Momentum gauge 0–100. Above 70 is overbought, below 30 oversold.
ATR
Average true range — the size of a typical day.
VWAP
20-day volume-weighted average price — the average paid over the last month; the page shows no intraday VWAP.
Supertrend
A trend-following stop line. A close through it flips the read.
Chandelier
A trailing stop set a few average ranges below the recent high.
Options & flow
Gamma / GEX
Dealer hedging pressure. Negative gamma amplifies moves both ways.
Call / put wall
The strikes with the heaviest open interest; they act as ceiling and floor.
Max pain
The strike where most options expire worthless.
13F · Form 4
Institutional filings, 45 days after quarter end. Insider trades, within two days.
Scoring
Composite signal
Independent factors scored and netted into one number.
Hit-rate
Share of past calls that resolved in the direction stated.
Brier score
Calibration measure. Lower means stated probabilities track reality.
HHI
Concentration 0–10,000. Above 2,500 means one segment carries the company.
EVT
Fits the tail rather than assuming a bell curve, so bad days are not understated.